Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Antineoplastics

Lack of efficacy : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shibata S, et al. [A Case of Pembrolizumab Therapy Markedly Effective for Advanced Recurrent Colorectal Cancer]. [Japanese]. Gan to Kagaku Ryoho 49: 1151-1153, No. 10, Oct 2022. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/36281616 [Japanese; summarised from a translation] Shibata S, et al. [A Case of Pembrolizumab Therapy Markedly Effective for Advanced Recurrent Colorectal Cancer]. [Japanese]. Gan to Kagaku Ryoho 49: 1151-1153, No. 10, Oct 2022. Available from: URL: https://​pubmed.​ncbi.​nlm.​nih.​gov/​36281616 [Japanese; summarised from a translation]
Metadaten
Titel
Antineoplastics
Lack of efficacy : case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41307-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Elasomeran

Case report

Dapsone